Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolism of pancreatic cancer: paving the way to better anticancer strategies
Authors
Keywords
-
Journal
Molecular Cancer
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-02
DOI
10.1186/s12943-020-01169-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Acetyl-CoA metabolism supports multi-step pancreatic tumorigenesis
- (2019) Alessandro Carrer et al. Cancer Discovery
- Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers
- (2019) Conan G. Kinsey et al. NATURE MEDICINE
- Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
- (2019) Kirsten L. Bryant et al. NATURE MEDICINE
- Topical Diclofenac Reprograms Metabolism and Immune Cell Infiltration in Actinic Keratosis
- (2019) Katrin Singer et al. Frontiers in Oncology
- Altered Gene Expression along the Glycolysis–Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer
- (2019) Joanna M. Karasinska et al. CLINICAL CANCER RESEARCH
- Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D culture platform of pancreatic cancer
- (2019) Mans Broekgaarden et al. BIOMATERIALS
- Metabolic Subtyping for Novel Personalized Therapies Against Pancreatic Cancer
- (2019) Kamiya Mehla et al. CLINICAL CANCER RESEARCH
- Real‐world outcomes of FOLFIRINOX vs gemcitabine and nab‐paclitaxel in advanced pancreatic cancer: A population‐based propensity score‐weighted analysis
- (2019) Kelvin K. W. Chan et al. Cancer Medicine
- FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Head Adenocarcinoma
- (2018) Mashaal Dhir et al. ANNALS OF SURGICAL ONCOLOGY
- Survival of the fittest: Cancer challenges T cell metabolism
- (2018) Davide G. Franchina et al. CANCER LETTERS
- Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
- (2018) Thomas M. Ashton et al. CLINICAL CANCER RESEARCH
- Pyruvate Kinase Isozyme M2 Plays a Critical Role in the Interactions Between Pancreatic Stellate Cells and Cancer Cells
- (2018) Atsushi Masamune et al. DIGESTIVE DISEASES AND SCIENCES
- Molecular targeted therapy: treating cancer with specificity
- (2018) Yeuan Ting Lee et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- MiR-21-mediated Metabolic Alteration of Cancer-associated Fibroblasts and Its Effect on Pancreatic Cancer Cell Behavior
- (2018) Shuo Chen et al. International Journal of Biological Sciences
- Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
- (2018) Courtney D. DiNardo et al. NEW ENGLAND JOURNAL OF MEDICINE
- The responsively decreased PKM2 facilitates the survival of pancreatic cancer cells in hypoglucose
- (2018) Xiang Li et al. Cell Death & Disease
- Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma
- (2018) Huilin Ye et al. Cell Death & Disease
- USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy
- (2018) Tao Ma et al. CANCER LETTERS
- Paracrine HGF/c-MET enhances the stem cell-like potential and glycolysis of pancreatic cancer cells via activation of YAP/HIF-1α
- (2018) Bin Yan et al. EXPERIMENTAL CELL RESEARCH
- Rescue of 2-Deoxyglucose Side Effects by Ketogenic Diet
- (2018) Martin Voss et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor microenvironment participates in metastasis of pancreatic cancer
- (2018) Bo Ren et al. Molecular Cancer
- Omega-3 Fatty Acids Prevent Early Pancreatic Carcinogenesis via Repression of the AKT Pathway
- (2018) Yongzeng Ding et al. Nutrients
- The Potential of CAR T Cell Therapy in Pancreatic Cancer
- (2018) Mehmet Akce et al. Frontiers in Immunology
- Significance of 18F-Fluorodeoxyglucose (FDG) Uptake in Response to Chemoradiotherapy for Pancreatic Cancer
- (2018) Hiroshi Kurahara et al. ANNALS OF SURGICAL ONCOLOGY
- Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity
- (2018) Vineet Kumar Gupta et al. CANCER LETTERS
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice
- (2018) Mouad Edderkaoui et al. GASTROENTEROLOGY
- LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
- (2018) Mengyu Feng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
- (2018) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic treatment of pancreatic cancer revisited
- (2018) Michel Ducreux et al. SEMINARS IN ONCOLOGY
- Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
- (2018) Naiara Santana-Codina et al. Nature Communications
- Stereotactic radiotherapy of pancreatic cancer: a systematic review on pain relief
- (2018) Milly Buwenge et al. Journal of Pain Research
- Pancreatic stellate cell activation is regulated by fatty acids and ER stress
- (2017) Yael Ben-Harosh et al. EXPERIMENTAL CELL RESEARCH
- Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations
- (2017) Lei Huang et al. GUT
- Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
- (2017) E Hessmann et al. GUT
- Targeting metabolic reprogramming in KRAS-driven cancers
- (2017) Kenji Kawada et al. International Journal of Clinical Oncology
- Up-regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine-resistant pancreatic cancer cells
- (2017) Hengqiang Zhao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)
- (2017) Guanggai Xia et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial
- (2017) Angela Alistar et al. LANCET ONCOLOGY
- Paraoxonase 2 Facilitates Pancreatic Cancer Growth and Metastasis by Stimulating GLUT1-Mediated Glucose Transport
- (2017) Arvindhan Nagarajan et al. MOLECULAR CELL
- mTOR Inhibition Restores Amino Acid Balance in Cells Dependent on Catabolism of Extracellular Protein
- (2017) Michel Nofal et al. MOLECULAR CELL
- Glucose feeds the TCA cycle via circulating lactate
- (2017) Sheng Hui et al. NATURE
- Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis
- (2017) Oliver G McDonald et al. NATURE GENETICS
- Connexin-43 channels are a pathway for discharging lactate from glycolytic pancreatic ductal adenocarcinoma cells
- (2017) T H Dovmark et al. ONCOGENE
- Stromal cues regulate the pancreatic cancer epigenome and metabolome
- (2017) Mara H. Sherman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Consuming a Ketogenic Diet while Receiving Radiation and Chemotherapy for Locally Advanced Lung Cancer and Pancreatic Cancer: The University of Iowa Experience of Two Phase 1 Clinical Trials
- (2017) Amir Zahra et al. RADIATION RESEARCH
- The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings
- (2017) Shahed N. Badiyan et al. Surgical Oncology Clinics of North America
- Metabolic Interactions in the Tumor Microenvironment
- (2017) Costas A. Lyssiotis et al. TRENDS IN CELL BIOLOGY
- Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions
- (2017) Guido Giordano et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis
- (2017) Shiou-Ling Jian et al. Cell Death & Disease
- Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
- (2017) Orianne Olivares et al. Nature Communications
- Critical role for arginase 2 in obesity-associated pancreatic cancer
- (2017) Tamara Zaytouni et al. Nature Communications
- Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism
- (2017) Douglas E. Biancur et al. Nature Communications
- Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers
- (2017) Laetitia Seguin et al. Cancer Discovery
- Disrupting glutamine metabolic pathways to sensitize gemcitabine-resistant pancreatic cancer
- (2017) Ru Chen et al. Scientific Reports
- Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer
- (2017) Jane Cullis et al. Cancer Immunology Research
- Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells
- (2017) Yoshiaki Sunami et al. Cancers
- Pancreatic Cancer Chemoresistance to Gemcitabine
- (2017) Manoj Amrutkar et al. Cancers
- Energy sources identify metabolic phenotypes in pancreatic cancer
- (2016) Chen Liang et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Amino acid transporter SLC6A14 is a novel and effective drug target for pancreatic cancer
- (2016) V Coothankandaswamy et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer
- (2016) Huai-Qiang Ju et al. CANCER LETTERS
- Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade
- (2016) Zhengle Zhang et al. CANCER LETTERS
- Current progress in immunotherapy for pancreatic cancer
- (2016) Kelly Foley et al. CANCER LETTERS
- Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation
- (2016) Christopher J. Tape et al. CELL
- Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity
- (2016) Thomas R. Flint et al. Cell Metabolism
- FBW7 (F-box and WD Repeat Domain-Containing 7) Negatively Regulates Glucose Metabolism by Targeting the c-Myc/TXNIP (Thioredoxin-Binding Protein) Axis in Pancreatic Cancer
- (2016) S. Ji et al. CLINICAL CANCER RESEARCH
- Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification
- (2016) Archana Bhaw-Luximon et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer
- (2016) Brian Z. Huang et al. JNCI-Journal of the National Cancer Institute
- Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
- (2016) Timothy M Nywening et al. LANCET ONCOLOGY
- FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
- (2016) Mustafa Suker et al. LANCET ONCOLOGY
- Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic Cancer
- (2016) Yi-Ping Wang et al. MOLECULAR CELL
- Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis
- (2016) Xinjian Li et al. MOLECULAR CELL
- Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion
- (2016) Cristovão M. Sousa et al. NATURE
- Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors
- (2016) Shawn M Davidson et al. NATURE MEDICINE
- Cancer metabolism: a therapeutic perspective
- (2016) Ubaldo E. Martinez-Outschoorn et al. Nature Reviews Clinical Oncology
- Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer
- (2016) J Li et al. ONCOGENE
- Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells
- (2016) Su Chii Kong et al. PANCREAS
- Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers
- (2016) J. R. Mayers et al. SCIENCE
- The Warburg Effect: How Does it Benefit Cancer Cells?
- (2016) Maria V. Liberti et al. TRENDS IN BIOCHEMICAL SCIENCES
- Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy
- (2016) J. Incio et al. Cancer Discovery
- Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials
- (2016) Catalina Mosquera et al. Cancer Genetics
- Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism
- (2016) Hongyun Zhao et al. eLife
- Influence of Statins and Cholesterol on Mortality Among Patients With Pancreatic Cancer
- (2016) Brian Z. Huang et al. JNCI-Journal of the National Cancer Institute
- Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma
- (2016) Hweixian Leong Penny et al. OncoImmunology
- Hypoxic repression of pyruvate dehydrogenase activity is necessary for metabolic reprogramming and growth of model tumours
- (2016) Tereza Golias et al. Scientific Reports
- The MUC1 oncomucin regulates pancreatic cancer cell biological properties and chemoresistance. Implication of p42–44 MAPK, Akt, Bcl-2 and MMP13 pathways
- (2015) Solange Tréhoux et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base
- (2015) Charles E. Rutter et al. CANCER
- Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer
- (2015) S. Kordes et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Four types of fatty acids exert differential impact on pancreatic cancer growth
- (2015) Ming Yu et al. CANCER LETTERS
- Therapeutic Targeting of the Warburg Effect in Pancreatic Cancer Relies on an Absence of p53 Function
- (2015) N. V. Rajeshkumar et al. CANCER RESEARCH
- Human Pancreatic Cancer Tumors Are Nutrient Poor and Tumor Cells Actively Scavenge Extracellular Protein
- (2015) J. J. Kamphorst et al. CANCER RESEARCH
- The Utilization of Extracellular Proteins as Nutrients Is Suppressed by mTORC1
- (2015) Wilhelm Palm et al. CELL
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells
- (2015) Patricia Sancho et al. Cell Metabolism
- Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells
- (2015) Dong Joon Kim et al. EXPERIMENTAL CELL RESEARCH
- Tumor mechanics and metabolic dysfunction
- (2015) Jason C. Tung et al. FREE RADICAL BIOLOGY AND MEDICINE
- Stromal biology and therapy in pancreatic cancer: a changing paradigm
- (2015) Albrecht Neesse et al. GUT
- Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
- (2015) LANCET
- Targeting pancreatic cancer using a combination of gemcitabine with the omega-3 polyunsaturated fatty acid emulsion, Lipidem™
- (2015) Jonathan Haqq et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism
- (2015) Rushika M. Perera et al. NATURE
- Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma
- (2015) Jean-Baptiste Bachet et al. PANCREAS
- Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma
- (2015) Fabienne Guillaumond et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors
- (2015) Anneleen Daemen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
- (2015) F. Hossain et al. Cancer Immunology Research
- Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors
- (2015) E. R. Manuel et al. Cancer Immunology Research
- Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation
- (2014) J J Souchek et al. BRITISH JOURNAL OF CANCER
- Knockdown or inhibition of aldo-keto reductase 1B10 inhibits pancreatic carcinoma growth via modulating Kras–E-cadherin pathway
- (2014) Wanying Zhang et al. CANCER LETTERS
- Repurposing of Metformin and Aspirin by Targeting AMPK-mTOR and Inflammation for Pancreatic Cancer Prevention and Treatment
- (2014) W. Yue et al. Cancer Prevention Research
- Cell Surface Lactate Receptor GPR81 Is Crucial for Cancer Cell Survival
- (2014) C. L. Roland et al. CANCER RESEARCH
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells
- (2014) I-Lu Lai et al. CARCINOGENESIS
- Metabolic Control of Autophagy
- (2014) Lorenzo Galluzzi et al. CELL
- Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy
- (2014) Mara H. Sherman et al. CELL
- FOXM1 Promotes the Warburg Effect and Pancreatic Cancer Progression via Transactivation of LDHA Expression
- (2014) J. Cui et al. CLINICAL CANCER RESEARCH
- Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs
- (2014) Daisuke Hashimoto et al. EUROPEAN JOURNAL OF CANCER
- Baseline Metabolic Tumor Volume and Total Lesion Glycolysis Are Associated With Survival Outcomes in Patients With Locally Advanced Pancreatic Cancer Receiving Stereotactic Body Radiation Therapy
- (2014) Avani S. Dholakia et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages
- (2014) Stanley Ching-Cheng Huang et al. NATURE IMMUNOLOGY
- Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development
- (2014) Jared R Mayers et al. NATURE MEDICINE
- Mass Spectrometry-Based Metabolic Profiling of Gemcitabine-Sensitive and Gemcitabine-Resistant Pancreatic Cancer Cells
- (2014) Yoshinori Fujimura et al. PANCREAS
- KRAS: feeding pancreatic cancer proliferation
- (2014) Kirsten L. Bryant et al. TRENDS IN BIOCHEMICAL SCIENCES
- Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer
- (2014) Julian Swierczynski WORLD JOURNAL OF GASTROENTEROLOGY
- Autophagy Is Critical for Pancreatic Tumor Growth and Progression in Tumors with p53 Alterations
- (2014) A. Yang et al. Cancer Discovery
- Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
- (2013) Y Ino et al. BRITISH JOURNAL OF CANCER
- Lysine-5 Acetylation Negatively Regulates Lactate Dehydrogenase A and Is Decreased in Pancreatic Cancer
- (2013) Di Zhao et al. CANCER CELL
- Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients
- (2013) Jung Yong Hong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
- (2013) Chih-Hao Chang et al. CELL
- Integration of Metabolomics and Transcriptomics Revealed a Fatty Acid Network Exerting Growth Inhibitory Effects in Human Pancreatic Cancer
- (2013) G. Zhang et al. CLINICAL CANCER RESEARCH
- nab-Paclitaxel mechanisms of action and delivery
- (2013) Denise A. Yardley JOURNAL OF CONTROLLED RELEASE
- Tumor-Derived Lactate Modifies Antitumor Immune Response: Effect on Myeloid-Derived Suppressor Cells and NK Cells
- (2013) Z. Husain et al. JOURNAL OF IMMUNOLOGY
- Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
- (2013) Cosimo Commisso et al. NATURE
- p53 status determines the role of autophagy in pancreatic tumour development
- (2013) Mathias T. Rosenfeldt et al. NATURE
- Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
- (2013) Jaekyoung Son et al. NATURE
- Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids
- (2013) J. J. Kamphorst et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma
- (2013) F. Guillaumond et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumour-associated mutant p53 drives the Warburg effect
- (2013) Cen Zhang et al. Nature Communications
- Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer
- (2012) K Kaira et al. BRITISH JOURNAL OF CANCER
- A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors
- (2012) Luis E. Raez et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
- (2012) Haoqiang Ying et al. CELL
- The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue Type
- (2012) Mariia O. Yuneva et al. Cell Metabolism
- Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma
- (2012) Yeon Tae Chung et al. MODERN PATHOLOGY
- Pancreatic Tumor Sensitivity to Plasma L-Asparagine Starvation
- (2012) Emmanuelle Dufour et al. PANCREAS
- Differential Expression of Metabolic Genes in Tumor and Stromal Components of Primary and Metastatic Loci in Pancreatic Adenocarcinoma
- (2012) Nina V. Chaika et al. PLoS One
- Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors
- (2012) T. Stylianopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer
- (2012) N. V. Chaika et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduction in circulating pro‐angiogenic and pro‐inflammatory factors is related to improved outcomes in patients with advanced pancreatic cancer treated with gemcitabine and intravenous omega‐3 fish oil
- (2012) Ali Arshad et al. HPB
- nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
- (2012) Kristopher K. Frese et al. Cancer Discovery
- Harnessing gemcitabine metabolism: a step towards personalized medicine for pancreatic cancer
- (2012) Muhammad Wasif Saif et al. Therapeutic Advances in Medical Oncology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
- (2011) Stephanos Pavlides et al. CELL CYCLE
- Pancreatic cancers require autophagy for tumor growth
- (2011) S. Yang et al. GENES & DEVELOPMENT
- Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy
- (2011) DONGDONG WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
- (2011) Patrick J. Loehrer et al. JOURNAL OF CLINICAL ONCOLOGY
- Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
- (2011) R. D. Michalek et al. JOURNAL OF IMMUNOLOGY
- Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo
- (2011) Zuzana Zachar et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Glutamine: pleiotropic roles in tumor growth and stress resistance
- (2011) Naval P. Shanware et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- The role of the Atg1/ULK1 complex in autophagy regulation
- (2010) Noboru Mizushima CURRENT OPINION IN CELL BIOLOGY
- Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress
- (2010) Shomit Sengupta et al. MOLECULAR CELL
- Glutamine addiction: a new therapeutic target in cancer
- (2010) David R. Wise et al. TRENDS IN BIOCHEMICAL SCIENCES
- Regulation Mechanisms and Signaling Pathways of Autophagy
- (2009) Congcong He et al. Annual Review of Genetics
- CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models
- (2009) W Schneiderhan et al. GUT
- Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
- (2009) J. Yun et al. SCIENCE
- Immunosurveillance of pancreatic adenocarcinoma: Insights from genetically engineered mouse models of cancer
- (2008) Carolyn E. Clark et al. CANCER LETTERS
- Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players
- (2008) M. P. Kim et al. CLINICAL CANCER RESEARCH
- Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells
- (2008) Candace M. Cham et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Oral mTOR Inhibitor Everolimus in Patients With Gemcitabine-Refractory Metastatic Pancreatic Cancer
- (2008) Brian M. Wolpin et al. JOURNAL OF CLINICAL ONCOLOGY
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
- 2-Deoxy-d-glucose causes cytotoxicity, oxidative stress, and radiosensitization in pancreatic cancer
- (2007) Mitchell C. Coleman et al. FREE RADICAL BIOLOGY AND MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started